Licensing Opportunity Identification
Discover and secure high-value global in-licensing and out-licensing opportunities
We enable our clients to identify promising assets, evaluate potential partners, and structure commercially sound deals that align with market realities and strategic goals
How you Benefit
Sourcing
Evaluation
Evaluation
Access curated licensing opportunities matched to your portfolio and growth strategy
Evaluation
Evaluation
Evaluation
Conduct comprehensive due diligence covering technical, regulatory, IP, and commercial aspects
Advisory
Evaluation
Advisory
Expert guidance throughout evaluation, negotiation, and closure stages
Who We Work With
Regional and Mid-Sized Pharmaceutical Companies
Regional and Mid-Sized Pharmaceutical Companies
Regional and Mid-Sized Pharmaceutical Companies
We support growth-focused pharma companies looking to strengthen or diversify their portfolios through in-licensing, partnerships, or dossier acquisitions. Our insights help them identify high-potential assets and accelerate market expansion
Dossier Developers and CDMOs
Regional and Mid-Sized Pharmaceutical Companies
Regional and Mid-Sized Pharmaceutical Companies
We collaborate with dossier owners, contract developers, and manufacturing organizations aiming to access new regions. Our expertise in regulatory pathways and partner identification enables smooth entry into emerging and established markets alike
Biotech and Specialty Pharma Firms
Regional and Mid-Sized Pharmaceutical Companies
Biotech and Specialty Pharma Firms
We assist innovation-driven companies in monetizing their R&D pipelines through out-licensing or co-development partnerships. Our network connects them with the right commercialization partners to maximize asset value and global reach
Investment firms
Regional and Mid-Sized Pharmaceutical Companies
Biotech and Specialty Pharma Firms
We work with investment firms evaluating opportunities in the pharmaceutical and biotech sectors. Our due diligence and market intelligence services help investors assess asset quality, growth potential, and deal viability with confidence